Pharmaceutical Research

EDITORIAL
pp. 101-101(1)

Drug Concentration, Binding, and Effect In Vivo
pp. 102-105(4)
Author: Holford N.H.G.

Nephelometric Immunoassay for Therapeutic Drug Level Monitoring
pp. 105-109(5)
Author: Nishikawa T.

Studies on the Mechanism of Fluoropyrimidine Cytotoxicity in L1210 Cells: Correlation with Inhibition of Thymidylate Synthetase but Not with Incorporation into RNA
pp. 110-115(6)
Authors: Danenberg K.D.; Becker D.; Mulkins M.A.; Danenberg P.V.

An Efficient In Vitro Assay for Acetylcholinesterase Reactivators Using Immobilized Enzyme
pp. 115-120(6)
Authors: Trammel A.M.; Simmons J.E.; Borchardt R.T.

Soft Drugs VI. The Application of the Inactive Metabolite Approach for Design of Soft -Blockers1?2
pp. 120-125(6)
Authors: Bodor N.; Oshiro Y.; Loftsson T.; Katovich M.; Caldwell W.

Irreversible Binding of Norethisterone to Human Serum Protein Induced by UV-B Light
pp. 126-129(4)
Authors: Sedee A.; van Henegouwen G.B.; Lusthof K.; Lodder G.

Site Specific Rectal Drug Administration in Man with an Osmotic System: Influence on “First-Pass” Elimination of Lidocaine
pp. 129-134(6)
Authors: de Leede L.G.J.; de Boer A.G.; Feijen C.D.; Breimer D.D.

Effect of Thyrotropin-Releasing Hormone on Lipoxygenase-Induced Hypotension in the Unanesthetized Guinea Pig
pp. 135-137(3)
Authors: Lux Jr W.E.; Feuerstein G.; Faden A.I.

Importance of Structural Free Space to the Solvent Power of Water
pp. 137-139(3)
Authors: Hüttenrauch R.; Zielke P.; Fricke S.

Lack of Tobramycin Distribution into Saliva
pp. 140-140(1)
Authors: Houglum J.E.; Cascella P.J.; Edwards G.B.